TABLE 2.

Potential small molecular drugs for LUAD patients.

Cmap name	Mean	n	Enrichment	p	Specificity	%non-null
Vorinostat	–0.553	12	–0.701	0	0.0885	91
Lynestreno	0.435	5	0.774	0.0013	0.0056	80
Sulfamerazine	0.464	5	0.772	0.00136	0	80
Amiodarone	0.458	5	0.768	0.0015	0.0069	80
Cefalexin	0.415	5	0.748	0.00236	0	80
Chlorpropamide	0.442	6	0.667	0.00381	0	83
Tetracycline	–0.525	5	–0.708	0.00457	0.0189	80
Fenbufen	0.402	6	0.611	0.01087	0	66
Cephaeline	0.439	5	0.619	0.02373	0.4795	80
Diazoxide	–0.555	5	–0.608	0.02597	0.0427	80
Vincamine	0.423	6	0.539	0.03693	0.162	66
Fluocinonide	0.413	5	0.584	0.03839	0.0746	80
Josamycin	–0.401	5	–0.562	0.04908	0.1	60